FDA Weighs Peptides Amid Conflicts | Global News

Peptides are exploding in popularity as wellness wonders — touted for muscle gains, faster healing, and anti-aging — but the FDA has little evidence they’re safe or effective. Health Secretary Robert F. Kennedy Jr., a self-proclaimed fan, wants to ease restrictions, sparking alarm among scientists who warn the lack of data is troubling. The FDA’s advisory panel, however, includes several members with financial ties to peptide companies — raising serious conflict-of-interest concerns. To counterbalance, the FDA added independent academics to the panel, which will vote on whether seven peptides should be allowed for compounding pharmacies. Though votes aren’t binding, public feedback — over 1,900 comments — is being closely considered. The FDA may opt for a temporary policy to protect pharmacies, with full approval likely taking much longer. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/dbc2589a896f1038